Lataa...
Pembrolizumab‐induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patient
Pembrolizumab is an immune checkpoint inhibitor with antitumor activity in other organ malignancies. We present this case —demonstrating multiple inflammatory adverse events associated with Pembrolizumab (in a single patient), in order to increase awareness and facilitate earlier identification of t...
Tallennettuna:
| Julkaisussa: | Clin Case Rep |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6452463/ https://ncbi.nlm.nih.gov/pubmed/30997084 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.2090 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|